Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 4, 2024
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
[ Mon, Mar 04th 2024
] - WOPRAI
Oren Livnat Maintained (ANIP) at Strong Buy with Increased Target to $83 on, Mar 4th, 2024
Oren Livnat of HC Wainwright & Co., Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $73 to $83 on, Mar 4th, 2024.
Oren has made no other calls on ANIP in the last 4 months.
There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, 0 agree with Oren's Rating of Hold.
This is the rating of the analyst that currently disagrees with Oren
- Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Increased Target to $80 on, Friday, March 1st, 2024
